D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
CALL
Sociedad Química y Minera de Chile
SQM
$20.5B
| $1.48M | ﹤0.01% |
+30,200
| New | +$1.42M |
|
2702
CALL
Groupon
GRPN
$765M
| $1.48M | ﹤0.01% |
111,200
-38,800
| -26% | -$591K |
|
2703
CALL
Ormat Technologies
ORA
$5.99B
| $1.48M | ﹤0.01% |
22,400
| – | – |
|
2704
PUT
Bunge Global
BG
$22.9B
| $1.48M | ﹤0.01% |
14,400
-3,100
| -18% | -$290K |
|
2705
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2B
| $1.48M | ﹤0.01% |
34,476
+29,354
| +573% | +$1.19M |
|
2706
PUT
Skyworks Solutions
SWKS
$13.7B
| $1.47M | ﹤0.01% |
13,600
-8,000
| -37% | -$839K |
|
|
FOLD
2707
DELISTED
Amicus Therapeutics
FOLD
| $1.47M | ﹤0.01% |
125,026
-161,198
| -56% | -$2.06M |
|
2708
Denison Mines
DNN
$2.62B
| $1.47M | ﹤0.01% |
751,800
+363,700
| +94% | +$690K |
|
2709
PUT
OneMain Financial
OMF
$7.01B
| $1.47M | ﹤0.01% |
28,800
-82,200
| -74% | -$3.93M |
|
2710
Corpay
CPAY
$26.5B
| $1.47M | ﹤0.01% |
4,768
-1,858
| -28% | -$533K |
|
2711
Fresenius Medical Care
FMS
$11.7B
| $1.47M | ﹤0.01% |
76,176
+60,831
| +396% | +$1.21M |
|
|
MASI
2712
PUT
DELISTED
Masimo
MASI
| $1.47M | ﹤0.01% |
10,000
-1,100
| -10% | -$142K |
|
|
RVNC
2713
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.47M | ﹤0.01% |
298,110
-113,640
| -28% | -$673K |
|
2714
Schneider National
SNDR
$5.71B
| $1.46M | ﹤0.01% |
64,668
+46,239
| +251% | +$1.1M |
|
2715
Trustmark
TRMK
$2.71B
| $1.46M | ﹤0.01% |
51,943
-52,810
| -50% | -$1.42M |
|
2716
CALL
iQIYI
IQ
$1.06B
| $1.46M | ﹤0.01% |
344,600
-256,400
| -43% | -$986K |
|
2717
Ocular Therapeutix
OCUL
$2.23B
| $1.46M | ﹤0.01% |
160,142
-230,693
| -59% | -$1.64M |
|
2718
Karyopharm Therapeutics
KPTI
$40.6M
| $1.45M | ﹤0.01% |
64,188
+23,040
| +56% | +$404K |
|
2719
Dover
DOV
$25.5B
| $1.45M | ﹤0.01% |
8,181
-9,135
| -53% | -$1.47M |
|
2720
Sportsman's Warehouse
SPWH
$46.6M
| $1.45M | ﹤0.01% |
465,608
+94,388
| +25% | +$351K |
|
2721
iShares MSCI India Small-Cap ETF
SMIN
$752M
| $1.45M | ﹤0.01% |
+20,588
| New | +$1.47M |
|
2722
CALL
Banco Macro
BMA
$4.91B
| $1.45M | ﹤0.01% |
+30,000
| New | +$1.06M |
|
2723
Skywest
SKYW
$3.71B
| $1.44M | ﹤0.01% |
20,894
-23,962
| -53% | -$1.42M |
|
2724
iShares US Oil Equipment & Services ETF
IEZ
$361M
| $1.44M | ﹤0.01% |
+61,023
| New | +$1.3M |
|
2725
B2Gold
BTG
$7.13B
| $1.44M | ﹤0.01% |
549,886
+450,122
| +451% | +$1.22M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.